[go: up one dir, main page]

ITMI922400A1 - Composizioni farmaceutiche contenenti una calcitonina - Google Patents

Composizioni farmaceutiche contenenti una calcitonina

Info

Publication number
ITMI922400A1
ITMI922400A1 IT002400A ITMI922400A ITMI922400A1 IT MI922400 A1 ITMI922400 A1 IT MI922400A1 IT 002400 A IT002400 A IT 002400A IT MI922400 A ITMI922400 A IT MI922400A IT MI922400 A1 ITMI922400 A1 IT MI922400A1
Authority
IT
Italy
Prior art keywords
calcitonin
pharmaceutical compositions
compositions containing
pharmaceutical
compositions
Prior art date
Application number
IT002400A
Other languages
English (en)
Inventor
Laura Chiodini
Teodoro Fonio
Gianfranco Rancati
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Publication of ITMI922400A0 publication Critical patent/ITMI922400A0/it
Priority to ITMI922400A priority Critical patent/IT1255895B/it
Priority to JP6509649A priority patent/JPH08505364A/ja
Priority to PCT/EP1993/002874 priority patent/WO1994008622A1/en
Priority to EP93922958A priority patent/EP0665755B1/en
Priority to US08/416,874 priority patent/US5719122A/en
Priority to DE69319440T priority patent/DE69319440T2/de
Priority to ES93922958T priority patent/ES2120516T3/es
Priority to AU51779/93A priority patent/AU5177993A/en
Priority to CN93118487A priority patent/CN1091314A/zh
Priority to ZA937697A priority patent/ZA937697B/xx
Priority to MX9306499A priority patent/MX9306499A/es
Publication of ITMI922400A1 publication Critical patent/ITMI922400A1/it
Application granted granted Critical
Publication of IT1255895B publication Critical patent/IT1255895B/it
Priority to GR980401789T priority patent/GR3027611T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI922400A 1992-10-20 1992-10-20 Composizioni farmaceutiche contenenti una calcitonina IT1255895B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI922400A IT1255895B (it) 1992-10-20 1992-10-20 Composizioni farmaceutiche contenenti una calcitonina
ES93922958T ES2120516T3 (es) 1992-10-20 1993-10-15 Preparacion de composiciones farmaceuticas que contienen una calcitonina.
PCT/EP1993/002874 WO1994008622A1 (en) 1992-10-20 1993-10-15 Pharmaceutical compositions containing a calcitonin
EP93922958A EP0665755B1 (en) 1992-10-20 1993-10-15 Preparation of pharmaceutical compositions containing a calcitonin
US08/416,874 US5719122A (en) 1992-10-20 1993-10-15 Pharmaceutical compositions containing a calcitonin
DE69319440T DE69319440T2 (de) 1992-10-20 1993-10-15 Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
JP6509649A JPH08505364A (ja) 1992-10-20 1993-10-15 カルシトニン含有医薬組成物
AU51779/93A AU5177993A (en) 1992-10-20 1993-10-15 Pharmaceutical compositions containing a calcitonin
CN93118487A CN1091314A (zh) 1992-10-20 1993-10-18 含有降钙素的药物组合物
ZA937697A ZA937697B (en) 1992-10-20 1993-10-18 Pharmaceutical compositions containing a calcitonin
MX9306499A MX9306499A (es) 1992-10-20 1993-10-19 Composiciones farmaceuticas que contienen una anfetamina.
GR980401789T GR3027611T3 (en) 1992-10-20 1998-08-07 Pharmaceutical compositions containing a calcitonin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922400A IT1255895B (it) 1992-10-20 1992-10-20 Composizioni farmaceutiche contenenti una calcitonina

Publications (3)

Publication Number Publication Date
ITMI922400A0 ITMI922400A0 (it) 1992-10-20
ITMI922400A1 true ITMI922400A1 (it) 1994-04-20
IT1255895B IT1255895B (it) 1995-11-17

Family

ID=11364142

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922400A IT1255895B (it) 1992-10-20 1992-10-20 Composizioni farmaceutiche contenenti una calcitonina

Country Status (12)

Country Link
US (1) US5719122A (it)
EP (1) EP0665755B1 (it)
JP (1) JPH08505364A (it)
CN (1) CN1091314A (it)
AU (1) AU5177993A (it)
DE (1) DE69319440T2 (it)
ES (1) ES2120516T3 (it)
GR (1) GR3027611T3 (it)
IT (1) IT1255895B (it)
MX (1) MX9306499A (it)
WO (1) WO1994008622A1 (it)
ZA (1) ZA937697B (it)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
GB2318056B (en) * 1995-08-08 1999-05-26 Danbiosyst Uk Composition for enhanced uptake of polar drugs from the colon
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
FR2773489B1 (fr) * 1998-01-15 2001-03-23 Immunotech Sa Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
CA2344306A1 (en) * 1998-09-21 2000-03-30 Amato Pharmaceutical Products, Ltd. Oral drug delivery system for enhancing the bioavailability of active form of glycyrrhizin
CN1361694A (zh) 1999-07-16 2002-07-31 天藤制药株式会社 粘膜吸收甘草甜素制剂
EP1251867A4 (en) * 2000-02-04 2004-12-08 Unigene Lab Inc NASAL CALCITON INFORMATION
US6531112B2 (en) * 2000-05-15 2003-03-11 Delrx Pharmaceutical Corporation Formulations for administering calcitonin and processes for preparing the same
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20040241310A1 (en) * 2001-08-16 2004-12-02 Sveibjorn Gizurarson Method of producing antibodies ex-vivo
CN1642576A (zh) * 2002-02-25 2005-07-20 药物发展有限公司 吸收增强剂
US6855332B2 (en) 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
EP1556009B2 (en) * 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
WO2004084859A2 (en) 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8157788B2 (en) * 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
US20050222539A1 (en) * 2004-03-30 2005-10-06 Pediamed Pharmaceuticals, Inc. Automatic injection device
JP2006169213A (ja) * 2004-12-20 2006-06-29 Pola Chem Ind Inc ゲル状組成物
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
JP2010502690A (ja) * 2006-09-08 2010-01-28 フォーミックス エルティーディー． 有色または着色可能発泡性組成物
WO2009007785A2 (en) * 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
EP1986473B1 (en) * 2007-04-03 2017-01-25 Tsinghua University Organic electroluminescent device
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) * 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
MX2011006765A (es) 2008-12-22 2011-11-01 Allergan Inc Administracion intranasal de desmopresina.
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
ES2929471T3 (es) 2009-06-18 2022-11-29 Acerus Pharmaceuticals Usa Llc Administración segura de desmopresina
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US10335390B2 (en) 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
US20190008784A1 (en) * 2017-07-07 2019-01-10 Symbiomix Therapeutics, Llc Novel secnidazole soft gelatin capsule formulations and uses thereof
CN116173187B (zh) * 2023-03-14 2024-05-10 哈尔滨医科大学 降钙素在制备防治支架内再狭窄药物中的应用、药物涂层支架及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
GB9120672D0 (en) * 1991-09-28 1991-11-06 Ciba Geigy Ag Pharmaceutical compositions
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems

Also Published As

Publication number Publication date
EP0665755B1 (en) 1998-07-01
ZA937697B (en) 1995-04-18
WO1994008622A1 (en) 1994-04-28
AU5177993A (en) 1994-05-09
JPH08505364A (ja) 1996-06-11
US5719122A (en) 1998-02-17
GR3027611T3 (en) 1998-11-30
ES2120516T3 (es) 1998-11-01
CN1091314A (zh) 1994-08-31
DE69319440D1 (de) 1998-08-06
IT1255895B (it) 1995-11-17
DE69319440T2 (de) 1998-11-19
EP0665755A1 (en) 1995-08-09
ITMI922400A0 (it) 1992-10-20
MX9306499A (es) 1994-06-30

Similar Documents

Publication Publication Date Title
ITMI922400A1 (it) Composizioni farmaceutiche contenenti una calcitonina
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
FI951098A7 (fi) Farmaseuttinen pakkaus
DE69420988D1 (de) Zahnärztliche Ausgabeeinrichtung
FI922958L (fi) Farmaceutisk sammansaettning
FI922316L (fi) Farmaceutisk sammansaettning
FI922252L (fi) Farmaceutisk sammansaettning
NO306602B1 (no) Pulverdispenser
NO179941C (no) Farmasöytisk forbindelse
DE69207355D1 (de) Kindersicherer Blister
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
DE69233258D1 (de) Pulverspender
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
MX9200622A (es) Composicion farmaceutica
ITMI922230A0 (it) Composizioni cosmetiche contenenti una vitamina e polietossilata
DE4294862T1 (de) Pharmazeutische Komposition
ITMI912703A0 (it) Composizioni farmaceutiche contenenti una calcitonina
IT8620865A0 (it) Composizioni farmaceutiche contenenti una calcitonina.
ITMI922885A1 (it) Composizioni farmaceutiche a rilascio controllato contenenti nicergolina
FI952377A7 (fi) Farmaseuttisia ibuprofeenikoostumuksia
FI962979A7 (fi) Hirudiinia sisältävät farmaseuttiset koostumukset
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
IL103226A0 (en) Pharmaceutical compositions containing calcitonin
DK136492D0 (da) A pharmaceutical formulation
ITMI920364A1 (it) Composizioni farmaceutiche a base di calcitonine

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971031